| CP146-5MG
| RecombiMAb anti-mouse CTLA-4 (CD152)
| 5 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0060-100MG
| InVivoPlus anti-mouse VEGFR-2
| 100 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0239-100MG
| InVivoPlus anti-mouse CD137 (4-1BB)
| 100 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0063-5MG
| InVivoPlus anti-mouse GITR
| 5 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0014-1MG
| InVivoSIM anti-human IL-6R (Tocilizumab Biosimilar)
| 1 mg
| BioXCell
| Functional assays, ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0101-5MG
| InVivoPlus anti-mouse PD-L1 (B7-H1)
| 5 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0036-25MG
| InVivoPlus anti-mouse NK1.1
| 25 mg
| BioXCell
| in vivo NK cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0307-5MG
| InVivoPlus anti-mouse CD16/CD32
| 5 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0290-50MG
| InVivoPlus rat IgG1 isotype control
| 50 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| SIM0009-25MG
| InVivoSIM anti-human PD-L1 (Atezolizumab Biosimilar)
| 25 mg
| BioXCell
| Flow Cytometry; Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0099-100MG
| InVivoPlus recombinant CTLA-4-Ig (hum./hum.)
| 100 mg
| BioXCell
|
|
| N/A
| N/
| Solicitar Precio
| Solicitar
|
| BP0083-5MG
| InVivoPlus mouse IgG1 isotype control
| 5 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| SIM0011-50MG
| InVivoSIM anti-human C5 (Eculizumab Biosimilar)
| 50 mg
| BioXCell
| Inhibition of the activation of C5, Functional ass
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0033-2-25MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0017-1-25MG
| InVivoPlus anti-mouse CD154 (CD40L)
| 25 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0003-3-50MG
| InVivoPlus anti-mouse CD4
| 50 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0014-100MG
| InVivoSIM anti-human IL-6R (Tocilizumab Biosimilar)
| 100 mg
| BioXCell
| Functional assays, ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0086-50MG
| InVivoPlus mouse IgG2b isotype control
| 50 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0090-50MG
| InVivoPlus rat IgG2b I sotype control
| 50 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| CP146-100MG
| RecombiMAb anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0146-100MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0174-25MG
| InVivoPlus anti-mouse LAG-3
| 25 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0016-2-100MG
| InVivoPlus anti-mouse CD40
| 100 mg
| BioXCell
| in vivo CD40 activation, in vitro B cell stimulati
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0117-5MG
| InVivoPlus anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0308-5MG
| InVivoPlus anti-rat CD4
| 5 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| SIM0011-100MG
| InVivoSIM anti-human C5 (Eculizumab Biosimilar)
| 100 mg
| BioXCell
| Inhibition of the activation of C5, Functional ass
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0060-50MG
| InVivoPlus anti-mouse VEGFR-2
| 50 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0057-100MG
| InVivoPlus anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-?
| 100 mg
| BioXCell
| in vivo TGF? neutralization, in vitro TGF? neutral
|
| Mouse
| mouse/human/rat/monkey/hamster/canine/bovin
| Solicitar Precio
| Solicitar
|
| BP0012-100MG
| InVivoPlus anti-mouse CD25 (IL-2R?)
| 100 mg
| BioXCell
| in vivo regulatory T cell depletion, Flow cytometr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0009-1MG
| InVivoSIM anti-human PD-L1 (Atezolizumab Biosimilar)
| 1 mg
| BioXCell
| Flow Cytometry; Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0004-1-5MG
| InVivoPlus anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0329-50MG
| InVivoPlus anti-mouse CD71 (TfR1)
| 50 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0050-50MG
| InVivoPlus anti-mouse IL-10R (CD210)
| 50 mg
| BioXCell
| in vivo blocking of IL-10/IL-10R signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0066-5MG
| InVivoPlus anti-mouse Thy1.2 (CD90.2)
| 5 mg
| BioXCell
| in vivo ILC depletion, in vivo T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0283-5MG
| InVivoPlus anti-human/mouse/rat CD47
| 5 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Mouse
| human/mouse/rat
| Solicitar Precio
| Solicitar
|
| RT0268-1MG
| ReadyTag anti-HA
| 1 mg
| BioXCell
| ELISA, Western blot, Immunoprecipitation, Immunofl
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0051-25MG
| InVivoPlus anti-mouse IL-12 p40
| 25 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0003-3-5MG
| InVivoPlus anti-mouse CD4
| 5 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0017-1-100MG
| InVivoPlus anti-mouse CD154 (CD40L)
| 100 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0274-5MG
| InVivoPlus anti-mouse TIGIT
| 5 mg
| BioXCell
| in vivo TIGIT stimulation, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0164-100MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0063-25MG
| InVivoPlus anti-mouse GITR
| 25 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0012-5MG
| InVivoPlus anti-mouse CD25 (IL-2R?)
| 5 mg
| BioXCell
| in vivo regulatory T cell depletion, Flow cytometr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0090-25MG
| InVivoPlus rat IgG2b I sotype control
| 25 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BP0213-50MG
| InVivoPlus anti-mouse CSF1R (CD115)
| 50 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF-R1 neut
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0091-100MG
| InVivoPlus polyclonal Armenian hamster IgG
| 100 mg
| BioXCell
|
|
| Armenian hamster
| N/
| Solicitar Precio
| Solicitar
|
| RT0265-25MG
| ReadyTag anti-GFP
| 25 mg
| BioXCell
| Western blot, Immunofluorescence
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0088-5MG
| InVivoPlus rat IgG1 isotype control (anti-HRP)
| 5 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BP0297-50MG
| InVivoPlus human IgG1 isotype control
| 50 mg
| BioXCell
|
|
| Human
| N/
| Solicitar Precio
| Solicitar
|
| CP150-1MG
| RecombiMAb mouse IgG2a (D265A) isotype control, anti-hen egg lysozyme
| 1 mg
| BioXCell
|
|
| Mouse
| Othe
| Solicitar Precio
| Solicitar
|